Detalles de la búsqueda
1.
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
Cancer Immunol Immunother
; 72(9): 2949-2960, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247023
2.
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis.
Cancer Immunol Immunother
; 72(11): 3717-3726, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37787790
3.
Combined analysis of imaging tumor capsule with imaging tumor size guides the width of resection margin for solitary hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int
; 21(6): 551-558, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000845
4.
Development and validation of T-ARMS-PCR to detect CYP2C19*17 allele.
J Clin Lab Anal
; 34(1): e23005, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31441095
5.
Radiation Therapy With Combination Therapy of Immune Checkpoint Inhibitors and Antiangiogenic Therapy for Hepatocellular Carcinoma.
Int J Radiat Oncol Biol Phys
; 118(5): 1461-1471, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37433375
6.
Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma.
J Immunother Cancer
; 12(6)2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38844407
7.
Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma.
Biomark Res
; 12(1): 26, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355603
8.
Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study.
Int J Surg
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704621
9.
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer.
Biomark Res
; 12(1): 56, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38831368
10.
Targeting proteostasis network in osteoporosis: Pathological mechanisms and therapeutic implications.
Ageing Res Rev
; 90: 102024, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532006
11.
Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC.
Front Immunol
; 14: 1084843, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733485
12.
The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance.
Am J Cancer Res
; 13(8): 3582-3590, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693157
13.
Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection.
Front Oncol
; 11: 667555, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33869071
14.
Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications.
Am J Transl Res
; 12(5): 2099-2109, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32509204
15.
MICA*049, not MICA*009, is associated with Behçet's disease in a Chinese population.
Sci Rep
; 9(1): 10856, 2019 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350414
16.
Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
World J Gastroenterol
; 25(37): 5630-5640, 2019 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31602163
17.
Application of Single-Tube Tri-Primer ARMS-PCR to Detect the NFKB1 ATTG Insertion/Deletion Polymorphism.
Genet Test Mol Biomarkers
; 22(7): 443-447, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020835
Resultados
1 -
17
de 17
1
Próxima >
>>